Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer
在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013222
Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S